hall 1 694 1 9700,	
obteniendoel71% 1 694 1 9405,	
>nivel 1 694 1 8865,	
deHBeAg 1 694 1 8821,	
[34-57 1 694 1 8422,	
	5 1 694 1 8178,	
18 1 694 1 8130,	
retardada 1 694 1 7178,	
individuos 1 694 1 7173,	
alérgica 1 694 1 7170,	
reacción 2 694 2 7169,7175,	
provocar 1 694 1 7167,	
sacarosa 1 694 1 7153,	
ml) 1 694 1 7148,	
informados 1 694 1 7136,	
sacarasa-isomaltasa 1 694 1 7125,	
galactosa 1 694 1 7121,	
glucosa 1 694 1 7119,	
fructosa 1 694 1 7113,	
raros 1 694 1 7107,	
problemas 2 694 2 7106,7114,	
(50 1 694 1 6215,	
mg) 2 694 2 6212,6216,	
(100 2 694 2 6211,7144,	
ml 2 694 2 6210,6214,	
20 3 694 3 6209,7147,9040,	
pálido 1 694 1 5726,	
amarillo 1 694 1 5725,	
incolora 1 694 1 5721,	
(E216) 1 694 1 5706,	
propilo 2 694 2 5705,7163,	
(E218) 1 694 1 5701,	
metilo 2 694 2 5700,7160,	
parahidroxibenzoato 3 694 3 5698,5703,7158,	
conservantes 1 694 1 5697,	
(sacarosa) 1 694 1 5695,	
Azúcar 1 694 1 5694,	
Excipientes 1 694 1 5693,	
contiene 3 694 3 5688,7149,7157,	
eu/ 1 694 1 5670,	
europa 1 694 1 5669,	
emea 1 694 1 5668,	
//www 1 694 1 5667,	
http 1 694 1 5666,	
(EMEA) 1 694 1 5665,	
Medicamentos 1 694 1 5664,	
Europea 1 694 1 5662,	
Agencia 1 694 1 5661,	
web 1 694 1 5658,	
página 1 694 1 5657,	
disponible 1 694 1 5654,	
detallada 1 694 1 5649,	
TEXTO 1 694 1 5646,	
REVISIÓN 1 694 1 5644,	
2004 1 694 1 5639,	
Julio 1 694 1 5628,	
29 2 694 2 5627,5637,	
autorización 2 694 2 5626,5636,	
AUTORIZACIÓN/RENOVACIÓN 1 694 1 5618,	
PRIMERA 1 694 1 5617,	
FECHA 2 694 2 5614,5641,	
EU/1/99/114/002 1 694 1 5612,	
NÚMERO(S) 1 694 1 5606,	
Unido 1 694 1 5603,	
0NN 1 694 1 5601,	
Road 1 694 1 5597,	
Greenford 2 694 2 5596,5598,	
Ltd 1 694 1 5595,	
	Glaxo 1 694 1 5593,	
COMERCIALIZACIÓN 2 694 2 5592,5610,	
AUTORIZACIÓN 3 694 3 5590,5608,5621,	
LA 4 694 4 5589,5616,5620,5643,	
locales 1 694 1 5585,	
exigencias 1 694 1 5584,	
envases 1 694 1 5577,	
productos 2 694 2 5571,7165,	
vinilo 1 694 1 5560,	
policloruro 1 694 1 5558,	
lámina 1 694 1 5555,	
alveolar 1 694 1 5551,	
embalaje 1 694 1 5550,	
84 1 694 1 5544,	
u 1 694 1 5543,	
28 1 694 1 5542,	
Estuches 1 694 1 5540,	
recipiente 1 694 1 5539,	
Naturaleza 1 694 1 5535,	
30ºC 1 694 1 5532,	
temperatura 1 694 1 5529,	
conservación 1 694 1 5525,	
Precauciones 2 694 2 5522,5563,	
validez 1 694 1 5517,	
14 1 694 1 6009,	
Periodo 1 694 1 5515,	
procede 1 694 1 5512,	
Incompatibilidades 1 694 1 5510,	
Estearato 1 694 1 5505,	
sodio 1 694 1 5504,	
Carboximetilalmidón 1 694 1 5502,	
microcristalina 1 694 1 5501,	
Celulosa 1 694 1 5500,	
comprimido 1 694 1 5499,	
Núcleo 1 694 1 5497,	
Lista 1 694 1 5494,	
FARMACÉUTICOS 1 694 1 5491,	
carcinogénico 1 694 1 5488,	
ratones 1 694 1 5482,	
ratas 1 694 1 5480,	
carcinogenicidad 1 694 1 5472,	
sistémicas 1 694 1 5463,	
exposiciones 1 694 1 5462,	
alcanzados 1 694 1 5451,	
preñados 1 694 1 5443,	
embrioletalidad 1 694 1 5436,	
induce 1 694 1 5435,	
hembras 1 694 1 5433,	
machos 1 694 1 5431,	
teratogenicidad 1 694 1 5421,	
genotoxicidad 1 694 1 5403,	
concluye 1 694 1 5392,	
pudo 1 694 1 5384,	
previstos 1 694 1 5374,	
plasmáticos 1 694 1 5372,	
60-70 1 694 1 5365,	
dieron 1 694 1 5359,	
genotóxica 1 694 1 5353,	
ratón 1 694 1 5349,	
linfoma 1 694 1 5347,	
citogenético 1 694 1 5339,	
mostró 1 694 1 5334,	
Estos 2 694 2 5308,7164,	
neutropenia 1 694 1 5307,	
eritrocitos 1 694 1 5305,	
recuento 1 694 1 5303,	
apreciados 1 694 1 5297,	
importantes 1 694 1 5296,	
peso 1 694 1 5290,	
reducciones 1 694 1 5286,	
indicadores 1 694 1 5277,	
altas 2 694 2 5270,5465,	
preclínicos 1 694 1 5240,	
excepto 1 694 1 5221,	
acompaña 1 694 1 5210,	
envejecimiento 1 694 1 5199,	
farmacocinético 1 694 1 5193,	
perfil 1 694 1 5192,	
ancianos 1 694 1 5190,	
Es 1 694 1 5117,	
Poblaciones 1 694 1 5095,	
70 1 694 1 5088,	
representa 2 694 2 5085,5397,	
orgánico) 1 694 1 5081,	
(sistema 1 694 1 5077,	
orina 1 694 1 5070,	
excreta 1 694 1 5063,	
l/h/kg 1 694 1 5049,	
Eliminación 1 694 1 5037,	
(5-10%) 1 694 1 5028,	
excreción 1 694 1 5003,	
2-4 1 694 1 4984,	
LCR/concentración 1 694 1 4978,	
ratio 1 694 1 4977,	
(LCR) 1 694 1 4972,	
líquido 1 694 1 4970,	
alcanza 1 694 1 4968,	
nervioso 1 694 1 4964,	
19 1 694 1 8707,	
penetra 1 694 1 4960,	
muestran 1 694 1 4957,	
plasmáticas 3 694 3 4947,5036,5363,	
intervalo 1 694 1 4938,	
presenta 1 694 1 4930,	
l/kg 1 694 1 4928,	
distribución 1 694 1 4923,	
volumen 1 694 1 4920,	
intravenosa 1 694 1 4918,	
realizados 2 694 2 4913,5478,	
Distribución 1 694 1 4909,	
administrar 1 694 1 4904,	
AUC) 1 694 1 4893,	
absorbida 1 694 1 4889,	
cantidad 1 694 1 4886,	
47 1 694 1 4881,	
(reducida 1 694 1 4878,	
tmax 1 694 1 4872,	
retraso 1 694 1 4870,	
020 1 694 1 4858,	
015-0 1 694 1 4857,	
µg/ml 2 694 2 4850,4859,	
1-1 1 694 1 4848,	
decir 1 694 1 4834,	
(Cmax) 1 694 1 4824,	
máximas 1 694 1 4823,	
gastrointestinal 1 694 1 4792,	
24 1 694 1 4778,	
45% 1 694 1 4770,	
19% 1 694 1 4763,	
variando 1 694 1 4761,	
observada 2 694 2 4758,5054,	
057) 1 694 1 4745,	
lamivudina; 1 694 1 4743,	
(42/191) 1 694 1 4741,	
22% 1 694 1 4740,	
estadísticamente 1 694 1 4721,	
índices 2 694 2 4699,4727,	
acerca 1 694 1 4691,	
necesita 1 694 1 4687,	
diarios) 1 694 1 4658,	
(hasta 1 694 1 4652,	
empleó 1 694 1 4643,	
mínimo 1 694 1 4641,	
grado 2 694 2 4640,5024,	
compuesta 1 694 1 4632,	
comprendidas 2 694 2 4621,4663,	
edades 2 694 2 4620,4662,	
286 1 694 1 4617,	
mEq/ml) 1 694 1 4593,	
bDNA 1 694 1 4588,	
[versión 1 694 1 4585,	
(VERSANT 1 694 1 4584,	
convirtieron 1 694 1 4575,	
93% 1 694 1 4566,	
(118/252) 1 694 1 4557,	
confirmada 1 694 1 4553,	
respectivamente) 1 694 1 4547,	
11% 1 694 1 4542,	
5%) 1 694 1 4509,	
1] 1 694 1 4586,	
(11/221 1 694 1 4508,	
11%) 1 694 1 4495,	
tratado 3 694 3 4474,4524,4538,	
16/215 1 694 1 4458,	
9% 1 694 1 4455,	
(17/436 1 694 1 4453,	
hepatocelular 1 694 1 4452,	
023) 1 694 1 4445,	
19/215 1 694 1 4441,	
4% 2 694 2 4438,4460,	
Child-Pugh 1 694 1 4435,	
mutagénica 2 694 2 5322,5378,	
porcentaje 1 694 1 4424,	
001) 1 694 1 4416,	
p=0 4 694 4 4415,4444,4461,4744,	
38/215 1 694 1 4410,	
8% 2 694 2 4405,4443,	
(34/436 1 694 1 4403,	
media) 1 694 1 4392,	
(32 1 694 1 4388,	
confirmadas 1 694 1 4382,	
(nº 1 694 1 8808,	
significativo 2 694 2 5174,5215,	
651 1 694 1 4370,	
controlado 2 694 2 4366,4613,	
32%) 1 694 1 4352,	
Metabolismo 1 694 1 4997,	
(14% 1 694 1 4350,	
inmunocompetentes 1 694 1 4347,	
hígado 2 694 2 4342,5292,	
64%) 1 694 1 4335,	
(36% 1 694 1 4333,	
concomitante 1 694 1 4313,	
inmunodepresión 1 694 1 4312,	
esperar 1 694 1 4308,	
76-100% 1 694 1 4304,	
cabo 2 694 2 4298,4325,	
supervivencia 1 694 1 4296,	
tenía 1 694 1 4285,	
injerto 1 694 1 4279,	
reinfección 1 694 1 4277,	
continuaba 1 694 1 4270,	
valores 1 694 1 4265,	
eficaz 1 694 1 4255,	
significativamente 1 694 1 4394,	
supresión 1 694 1 4254,	
demostró 1 694 1 4252,	
administró 1 694 1 4244,	
inapropiados 1 694 1 4235,	
positivos) 1 694 1 4142,	
(HBeAg 1 694 1 4138,	
cuarenta 1 694 1 4136,	
abierto 1 694 1 4133,	
brazo 1 694 1 4132,	
incluyeron 1 694 1 4129,	
sola 1 694 1 4126,	
(3/47) 1 694 1 4122,	
combinada 1 694 1 4117,	
31% 1 694 1 4109,	
log10 3 694 3 4076,4087,4197,	
dipivoxilo 2 694 2 4048,4168,	
adefovir 2 694 2 4047,4167,	
10 4 694 4 4044,4164,5640,6213,	
(n=95) 1 694 1 4040,	
(NUC20904) 1 694 1 4030,	
ciego 1 694 1 4015,	
manejo 1 694 1 3995,	
Todavía 1 694 1 3989,	
hepáticos 1 694 1 3988,	
necroinflamatorios 1 694 1 3987,	
elevación 2 694 2 3961,9674,	
asociado 2 694 2 3933,9646,	
aumentando 2 694 2 3915,9628,	
24% 2 694 2 3906,9619,	
aproximadamente 7 694 7 3904,4827,4993,5046,5086,5364,9617,	
da 2 694 2 3892,9605,	
monoterapia 3 694 3 3889,4097,9602,	
impacto 3 694 3 3882,5173,9595,	
Frecuencia 2 694 2 3872,9585,	
Ningún 2 694 2 3862,9575,	
(31%) 2 694 2 3854,9567,	
8/26 2 694 2 3853,9566,	
empeoraron 4 694 4 3831,3855,9544,9568,	
1/22 2 694 2 3829,9542,	
14/22 2 694 2 3819,9532,	
Datos 1 694 1 5239,	
(37%) 2 694 2 3809,9520,	
18/49 2 694 2 3808,9519,	
4/26 2 694 2 3843,9556,	
necroinflamación 6 694 6 3806,3827,3851,9517,9540,9564,	
bioquímica 1 694 1 4036,	
así 2 694 2 3798,9509,	
32/68 2 694 2 3792,9503,	
(43%) 2 694 2 3790,9501,	
detectó 4 694 4 3784,4486,4505,9495,	
Tras 3 694 3 3764,4809,9475,	
procedentes 2 694 2 3749,9460,	
(tmax) 1 694 1 4818,	
(70%) 2 694 2 3739,9450,	
interrumpió 2 694 2 3729,9440,	
IAH 2 694 2 3721,9432,	
38% 2 694 2 3717,9428,	
67% 4 694 4 3711,3918,9422,9631,	
71% 1 694 1 3695,	
obteniendo 1 694 1 3693,	
iniciales 2 694 2 3670,9382,	
OMS 2 694 2 3655,9367,	
modificado 2 694 2 3652,9364,	
criterio 2 694 2 3651,9363,	
histológicamente 1 694 1 4383,	
acuerdo 3 694 3 3649,5581,9361,	
Grado 2 694 2 3646,9358,	
Toxicidad 2 694 2 3644,9356,	
representado 2 694 2 3636,9348,	
>2 2 694 2 3623,9335,	
basal; 2 694 2 3620,9332,	
8/116 2 694 2 3614,9326,	
(15%) 4 694 4 3613,3844,9325,9557,	
21/137 2 694 2 3612,9324,	
absoluta>500 2 694 2 3610,9322,	
(8%) 2 694 2 3602,9314,	
(21%) 2 694 2 3600,9312,	
ocasionales 1 694 1 5287,	
29/137 2 694 2 3599,9311,	
22/116 2 694 2 3592,9304,	
= 3 694 3 3657,7146,9369,	
(27%) 2 694 2 3591,9303,	
(15/436 1 694 1 4436,	
37/137 2 694 2 3590,9302,	
Anormal 2 694 2 3582,9294,	
ALT/ 2 694 2 3580,9292,	
Elevación 2 694 2 3578,9290,	
Pacientes 3 694 3 3576,8806,9288,	
Elevaciones 2 694 2 3564,9276,	
baja 4 694 4 3551,4949,5020,9263,	
proporción 2 694 2 3532,9244,	
recibieron 8 694 8 3522,3557,4094,4115,4124,4572,9234,9269,	
semana 3 694 3 3513,4766,9225,	
68 2 694 2 3504,9216,	
52 8 694 8 3502,3514,4061,4181,4327,4767,9214,9226,	
absorbe 1 694 1 4787,	
comparación 4 694 4 3492,4079,4497,9204,	
muestra 2 694 2 3490,9202,	
recibido 4 694 4 3476,3483,9188,9195,	
iniciarlo 2 694 2 3461,9173,	
semanas 7 694 7 3451,3501,4062,4182,4328,9163,9213,	
16 3 694 3 3450,7102,9162,	
control 2 694 2 3441,9153,	
reanudación 2 694 2 3439,9151,	
re- 2 694 2 3423,9136,	
debería 2 694 2 3420,9133,	
constante 2 694 2 3419,9132,	
Placebo 2 694 2 3584,9296,	
mantengan 2 694 2 3415,9128,	
mantienen 2 694 2 3410,9123,	
pequeño 1 694 1 5023,	
respuestas 2 694 2 3405,9118,	
sujetos 2 694 2 3387,9100,	
39% 2 694 2 3384,9097,	
ocurrió 2 694 2 3381,9094,	
interrumpieron 4 694 4 3372,3508,9085,9220,	
seguimiento 4 694 4 3365,3448,9078,9160,	
plazo 3 694 3 3363,5475,9076,	
(47%) 2 694 2 3793,9504,	
recaídas 2 694 2 3354,9067,	
ocurrir 2 694 2 3353,9066,	
duraderas 2 694 2 3343,9056,	
clínica 4 694 4 3340,3408,9053,9121,	
remisión 2 694 2 3339,9052,	
serológica 6 694 6 3336,3406,3418,9049,9119,9131,	
Después 2 694 2 3328,9041,	
(7%) 4 694 4 3326,3615,9038,9327,	
2/27 2 694 2 3325,9037,	
(74%) 2 694 2 3317,9029,	
20/27 2 694 2 3316,9028,	
(23%) 2 694 2 3307,9019,	
9/39 2 694 2 3306,9018,	
necroinflamatoria 4 694 4 3304,3323,9016,9035,	
(46%) 2 694 2 3297,9009,	
status 2 694 2 3277,8989,	
Meq/ml) 2 694 2 3268,8980,	
0 7 694 7 3266,4085,4591,4856,4995,5047,8978,	
Quantiplex 2 694 2 3264,8976,	
pg/ml) 2 694 2 3260,8972,	
(LLOD 4 694 4 3256,3265,8968,8977,	
Ensayo 4 694 4 3249,3262,8961,8974,	
Límite 4 694 4 3245,3658,8957,9370,	
momento 2 694 2 3233,8945,	
salvaje 2 694 2 3230,8942,	
tipo 2 694 2 3229,8941,	
95% 2 694 2 3227,8939,	
-YMDD 1 694 1 3222,	
período 4 694 4 3210,3528,8921,9240,	
instante 2 694 2 3205,8916,	
categorizados 4 694 4 3190,3218,8900,8929,	
Normalización 2 694 2 3158,8867,	
positivo 4 694 4 3150,3154,8860,8864,	
Semana 4 694 4 3146,3169,8856,8879,	
Basal 4 694 4 3143,3161,8853,8871,	
(1/18) 2 694 2 3141,8851,	
(2/40) 2 694 2 3139,8849,	
límite 2 694 2 3705,9416,	
detectable 2 694 2 3137,8847,	
> 7 694 7 3129,3155,3185,3226,8839,8895,8938,	
LNS2 2 694 2 3125,8835,	
basal 20 694 20 3122,3128,3153,3157,3179,3187,3589,3598,3607,3630,8832,8838,8863,8866,8889,8897,9301,9310,9319,9342,	
Todos 2 694 2 3117,8827,	
(13/18) 2 694 2 3115,8825,	
72 2 694 2 3114,8824,	
38 2 694 2 3112,8822,	
Seroconversión 2 694 2 3109,8820,	
HBV 1 694 1 3108,	
Estado 2 694 2 3105,8813,	
No-YMDD1 1 694 1 3104,	
orden 1 694 1 4845,	
YMDD1 3 694 3 3103,8810,8812,	
NUCB3018 2 694 2 3102,8805,	
asiático) 2 694 2 3101,8804,	
(Estudio 2 694 2 3100,8803,	
Resultados 2 694 2 3089,8792,	
resultados 3 694 3 3076,5467,8780,	
últimos 2 694 2 3075,8779,	
resumen 2 694 2 3073,8777,	
indetectables 2 694 2 3059,8763,	
TITULAR 1 694 1 5587,	
tuvieron 6 694 6 3053,3369,3536,8757,9082,9248,	
Al 2 694 2 3044,8748,	
LNS 8 694 8 3043,3132,3625,3656,8747,8842,9337,9368,	
>2x 2 694 2 3042,8746,	
central 1 694 1 4965,	
previos 6 694 6 3039,3065,3971,8743,8769,9685,	
cefalorraquídeo 1 694 1 4971,	
(20/26) 2 694 2 3031,8735,	
77% 2 694 2 3030,8734,	
seroconvirtieron 2 694 2 3028,8732,	
ALT; 4 694 4 3027,3714,8731,9425,	
aumentó 2 694 2 3020,8724,	
respectivamente 4 694 4 3015,3797,8719,9508,	
(15/32) 2 694 2 3014,8718,	
47% 3 694 3 3013,4556,8717,	
(28/58) 2 694 2 3011,8715,	
48 2 694 2 3009,8713,	
periodo 4 694 4 3001,3238,8704,8950,	
final 4 694 4 2999,3045,8702,8749,	
normalización 8 694 8 2995,3712,3775,4099,4262,8698,9423,9486,	
velocidad 4 694 4 2993,4396,4464,8696,	
tasa 10 694 10 2986,3804,3825,3849,4294,4315,8689,9515,9538,9562,	
(NUCB3018) 2 694 2 2984,8687,	
asiáticos 2 694 2 2983,8686,	
estudio 17 694 17 2977,3212,3243,3360,3752,3771,4013,4135,4365,4583,4612,8680,8923,8955,9073,9463,9482,	
progresó 4 694 4 2972,3869,8675,9582,	
(6%) 2 694 2 2957,8660,	
administra 1 694 1 5440,	
4/68 2 694 2 2956,8659,	
pre-tratamiento 6 694 6 2948,3837,3861,8651,9550,9574,	
(11/82) 2 694 2 2929,8631,	
13 2 694 2 2927,8629,	
5% 4 694 4 2916,3197,8618,8907,	
(63%) 2 694 2 2898,8599,	
19/30 2 694 2 2897,8598,	
(71%) 2 694 2 2877,8578,	
40/56 2 694 2 2876,8577,	
(50%) 4 694 4 2869,2908,8570,8610,	
41/82 2 694 2 2868,8569,	
mejoría 17 694 17 2855,2888,3300,3319,3719,3801,3822,3846,4203,8556,8589,9012,9031,9430,9512,9535,9559,	
dio 5 694 5 2850,4063,4183,4866,8551,	
primer 2 694 2 2844,8545,	
lograron 2 694 2 2837,8538,	
continuo 2 694 2 2826,8527,	
3-17 2 694 2 2815,8516,	
progresión 12 694 12 2810,2821,2950,3975,4398,4466,4513,4531,8511,8522,8653,9689,	
redujo 3 694 3 2808,4393,8509,	
bacterias 1 694 1 5327,	
[IAH]) 2 694 2 2806,8507,	
Knodell 2 694 2 2805,8506,	
Histológica 2 694 2 2803,8504,	
Actividad 2 694 2 2802,8503,	
Índice 2 694 2 2800,8501,	
puntos 2 694 2 2797,8498,	
superior 8 694 8 2794,3247,3660,4332,5530,8495,8959,9372,	
descenso 3 694 3 2791,4187,8492,	
tenían 2 694 2 2789,8490,	
(38-52 2 694 2 2785,8486,	
80-85 1 694 1 4807,	
y/o 2 694 2 3983,9697,	
histología 2 694 2 2784,8485,	
mejoró 2 694 2 2782,8483,	
convencional] 2 694 2 2777,8478,	
ensayo 8 694 8 2776,3078,4587,5338,5345,8436,8477,8782,	
[por 2 694 2 2775,8476,	
HBeAc 2 694 2 2768,8469,	
pacientes) 6 694 6 2756,2781,2818,8457,8482,8519,	
volvieron 2 694 2 3740,9451,	
nivel 9 694 9 2750,3152,3156,3178,3186,8451,8862,8888,8896,	
normalizó 2 694 2 2748,8449,	
6pg/ml)} 2 694 2 2747,8448,	
LLOD 3 694 3 2744,4589,8445,	
Genostics 4 694 4 2743,3255,8444,8967,	
terapéutico 1 694 1 3996,	
Abbott 4 694 4 2742,3254,8443,8966,	
hibridación 4 694 4 2738,3251,8439,8963,	
(ensayo 2 694 2 2736,8437,	
g 1 694 1 7151,	
límites 2 694 2 2733,8432,	
estaban 2 694 2 2728,8427,	
34-57 1 694 1 2723,	
[ 1 694 1 2722,	
suprimió 2 694 2 2712,8412,	
comparables 1 694 1 5448,	
año 17 694 17 2709,2845,3207,3235,3458,3724,3912,4210,4301,4731,8409,8546,8918,8947,9170,9435,9625,	
gamma 2 694 2 2686,8386,	
incorpora 2 694 2 2671,8371,	
disminuir 2 694 2 2663,8363,	
potencial 3 694 3 2659,5487,8359,	
Presenta 2 694 2 2657,8357,	
tóxicos 2 694 2 2655,8355,	
carecía 2 694 2 2652,8352,	
3mg/kg 1 694 1 4647,	
vio 3 694 3 2649,4896,8349,	
mitocondrial 8 694 8 2639,2668,2677,2688,8339,8368,8377,8388,	
estructura 2 694 2 2638,8338,	
post-tratamiento 8 694 8 3471,3498,3540,3567,9183,9210,9252,9279,	
potenciales 2 694 2 2631,8331,	
relativos 2 694 2 2628,8328,	
contenido 7 694 7 2617,2643,2665,5537,8317,8343,8365,	
escaso 2 694 2 2613,8313,	
Además 2 694 2 2609,8309,	
mamíferos 4 694 4 2608,2624,8308,8324,	
polimerasas 2 694 2 2606,8306,	
beta 2 694 2 2604,8304,	
alfa 2 694 2 2602,8302,	
inhibidor 4 694 4 2599,2682,8299,8382,	
débil 2 694 2 2598,8298,	
También 6 694 6 2595,3269,4127,4199,8295,8981,	
puntuación 1 694 1 4433,	
deoxinucleótidos 2 694 2 2594,8294,	
normal 17 694 17 2591,3162,3167,3171,3176,3184,3246,3659,5200,8291,8872,8877,8881,8886,8894,8958,9371,	
celular 2 694 2 2590,8290,	
interfiere 2 694 2 2586,8286,	
Absorción 1 694 1 4784,	
Lamivudina-TP 2 694 2 2584,8284,	
terminación 2 694 2 2580,8280,	
posterior 4 694 4 2579,3380,8279,9093,	
cadena 2 694 2 2577,8277,	
suprimido 2 694 2 3701,9412,	
lamivudina-TP 4 694 4 2574,2610,8274,8310,	
bloquea 2 694 2 2570,8270,	
formación 2 694 2 2564,8264,	
polimerasa 4 694 4 2559,2687,8259,8387,	
sustrato 2 694 2 2556,8256,	
actúa 4 694 4 2554,2680,8254,8380,	
-TP 2 694 2 2553,8253,	
vitro 4 694 4 2551,5341,5380,8251,	
in 6 694 6 2550,5340,5354,5379,5389,8250,	
horas 4 694 4 2549,4985,5060,8249,	
17-19 2 694 2 2548,8248,	
semivida 3 694 3 2539,5051,8239,	
13% 1 694 1 4734,	
original 2 694 2 2537,8237,	
compuesto 2 694 2 2536,8236,	
(TP) 2 694 2 2529,8229,	
trifosfato 4 694 4 2528,2542,8228,8242,	
derivado 2 694 2 2527,8227,	
infectadas 4 694 4 2521,2525,8221,8225,	
células 4 694 4 2520,2622,8220,8322,	
metabolizada 2 694 2 2517,8217,	
experimentalmente 2 694 2 2514,8214,	
estudiadas 2 694 2 2509,8209,	
celulares 2 694 2 2508,8208,	
líneas 2 694 2 2507,8207,	
J05AF05 2 694 2 2489,8189,	
ATC 2 694 2 2488,8188,	
código 2 694 2 2487,8187,	
farmacoterapéutico 2 694 2 2483,8183,	
Grupo 2 694 2 2482,8182,	
farmacodinámicas 2 694 2 2481,8181,	
conservar 1 694 1 5527,	
Propiedades 3 694 3 2480,4782,8180,	
	 1 694 1 2476,	
ESTE 2 694 2 2474,8176,	
FARMACOLÓGICAS 2 694 2 2472,8174,	
PROPIEDADES 2 694 2 2471,8173,	
estudiado 2 694 2 2469,8171,	
sobredosificación 2 694 2 2463,8165,	
continua 2 694 2 2457,8159,	
emplearse 2 694 2 2454,8156,	
dializable 2 694 2 2452,8154,	
Dado 2 694 2 2448,8150,	
apoyo 2 694 2 2443,8145,	
vigilará 2 694 2 2434,8136,	
caso 2 694 2 2430,8132,	
específicos 2 694 2 2424,8125,	
nucleósido 2 694 2 2486,8186,	
síntomas 4 694 4 2421,3979,8122,9693,	
recuperaron 2 694 2 2416,8117,	
fallecimientos 2 694 2 2410,8111,	
hubo 2 694 2 2409,8110,	
agudas 2 694 2 2405,8106,	
sobredosis 6 694 6 2404,2428,2432,8105,8129,8134,	
ingestión 2 694 2 2402,8103,	
consecuencias 2 694 2 2399,8100,	
produjo 7 694 7 2387,2895,2954,4106,8088,8596,8657,	
elevadas 4 694 4 2383,5256,5368,8084,	
aguda 2 694 2 2377,8078,	
6% 1 694 1 4121,	
(40-72 2 694 2 2753,8454,	
Sobredosis 2 694 2 2370,8071,	
9 4 694 4 2369,4093,5613,8070,	
medio 6 694 6 4083,4188,4817,4921,4975,5041,	
recibían 2 694 2 2360,8061,	
análogos 3 694 3 2342,5331,8043,	
biodisponibilidad 1 694 1 4795,	
terapia 9 694 9 2338,3914,3923,3974,4116,8039,9627,9636,9688,	
relacionada 2 694 2 2327,8028,	
normalmente 3 694 3 2326,4804,8027,	
láctica 4 694 4 2325,2356,8026,8057,	
renovación 1 694 1 5633,	
9/116 2 694 2 3601,9313,	
acidosis 4 694 4 2324,2355,8025,8056,	
	6 1 694 1 5492,	
mortales 2 694 2 2322,8023,	
diferencias 2 694 2 2298,7999,	
hereditaria 1 694 1 7110,	
parestesia) 2 694 2 2288,7989,	
(o 2 694 2 2287,7988,	
neuropatía 2 694 2 2285,7986,	
pancreatitis 2 694 2 2283,7984,	
casos 6 694 6 2281,2319,2353,7982,8020,8054,	
comunicado 6 694 6 2280,2318,2351,7981,8019,8052,	
rabdomiolisis 2 694 2 2271,7972,	
calambres 2 694 2 2269,7970,	
mialgia 2 694 2 2268,7969,	
musculares 2 694 2 2266,7967,	
Frecuentes 2 694 2 2259,7960,	
tejido 2 694 2 2257,7958,	
musculoesqueléticos 2 694 2 2254,7955,	
raramente 4 694 4 2244,2352,7945,8053,	
remitido 2 694 2 2241,7942,	
detectadas 2 694 2 2227,7928,	
(15/40) 2 694 2 3113,8823,	
exacerbaciones 2 694 2 2223,7924,	
notificado 2 694 2 2222,7923,	
copias/ml 3 694 3 4077,4088,4198,	
apartado 2 694 2 2208,7909,	
Incrementos 4 694 4 2204,2260,7905,7961,	
Middlesex 1 694 1 5599,	
hepatobiliares 2 694 2 2201,7902,	
Muy 6 694 6 2197,2202,2263,7898,7903,7964,	
linfático 2 694 2 2196,7897,	
Trastornos 8 694 8 2189,2200,2253,2265,7890,7901,7954,7966,	
clasificaron 2 694 2 2183,7884,	
22/44 2 694 2 2907,8609,	
comercialización 2 694 2 2181,7882,	
post- 2 694 2 2180,7881,	
continuada 1 694 1 4776,	
vigilancia 2 694 2 2179,7880,	
identificadas 2 694 2 2176,7877,	
fármaco 2 694 2 2175,7876,	
grupos 4 694 4 2167,3868,7868,9581,	
mejoraron 4 694 4 2870,2886,8571,8587,	
previa 2 694 2 2164,7865,	
ensayos 3 694 3 2154,5325,7855,	
partir 2 694 2 2150,7851,	
determinaron 2 694 2 2148,7849,	
calcular 2 694 2 2132,7833,	
conejos 1 694 1 5442,	
adecuados 2 694 2 2130,7831,	
	Prospectos 1 694 1 9701,	
estimadas 2 694 2 2118,7819,	
siguientes 2 694 2 2114,7815,	
asignadas 2 694 2 2111,7812,	
000) 2 694 2 2106,7807,	
nucleósidos 3 694 3 2344,5333,8045,	
(< 2 694 2 2104,7805,	
1/1000) 2 694 2 2101,7802,	
000 2 694 2 2099,7800,	
1/10 4 694 4 2098,2105,7799,7806,	
raras 12 694 12 2096,2103,2185,2188,2198,2264,7797,7804,7886,7889,7899,7965,	
Group 1 694 1 5594,	
óptimo 1 694 1 3997,	
1/1000 2 694 2 2093,7794,	
experimentaron 5 694 5 3298,3318,4428,9010,9030,	
< 15 694 15 2088,2094,2100,2745,3151,3177,3257,4590,7789,7795,7801,8446,8861,8887,8969,	
1/100 2 694 2 2087,7788,	
actividad 6 694 6 3303,3322,5335,5377,9015,9034,	
1/10) 4 694 4 2084,2089,7785,7790,	
( 8 694 8 2083,2086,2092,2097,7784,7787,7793,7798,	
frecuentes 12 694 12 2082,2085,2091,2144,2146,2203,7783,7786,7792,7845,7847,7904,	
definen 2 694 2 2079,7780,	
relacionadas 2 694 2 2073,7774,	
posiblemente 2 694 2 2072,7773,	
consideradas 2 694 2 2069,7770,	
únicamente 2 694 2 2064,7765,	
asignan 2 694 2 2063,7764,	
categorías 6 694 6 2059,2108,3641,7760,7809,9353,	
indujo 2 694 2 2757,8458,	
Las 10 694 10 2058,2076,2107,2135,2171,7759,7777,7808,7836,7872,	
órgano 5 694 5 2055,2391,5264,7756,8092,	
Fecha 2 694 2 5622,5630,	
(320/345) 1 694 1 4567,	
corporal 2 694 2 2054,7755,	
clasificadas 4 694 4 2051,2141,7752,7842,	
continuación 2 694 2 2045,7746,	
UI/l 2 694 2 3611,9323,	
A 4 694 4 2044,4830,5266,7745,	
diarrea 2 694 2 2043,7744,	
vómitos 2 694 2 2041,7742,	
abdominales 2 694 2 2039,7740,	
dolor 2 694 2 2036,7737,	
cefalea 2 694 2 2035,7736,	
amígdalas 2 694 2 2034,7735,	
vivo 2 694 2 5355,5390,	
garganta 2 694 2 2032,7733,	
molestias 4 694 4 2029,2038,7730,7739,	
respiratorio 2 694 2 2028,7729,	
intolerancia 1 694 1 7109,	
tracto 3 694 3 2027,4791,7728,	
infecciones 2 694 2 2025,7726,	
(64%) 2 694 2 3820,9533,	
fatiga 2 694 2 2024,7725,	
malestar 2 694 2 2022,7723,	
comunes 2 694 2 2020,7721,	
comunicados 2 694 2 2018,7719,	
placebo 21 694 21 2009,2170,2310,3484,3523,3561,3573,4232,4368,4414,4540,4615,4716,4737,7710,7871,8011,9196,9235,9273,9285,	
habían 4 694 4 3475,3482,9187,9194,	
tratados 14 694 14 2007,2012,2168,2308,2313,3760,4561,4773,7708,7713,7869,8009,8014,9471,	
similar 7 694 7 2003,3553,3684,4755,7704,9265,9396,	
CPK 4 694 4 1998,2262,7699,7963,	
Reino 1 694 1 5602,	
incrementos 2 694 2 1994,7695,	
rata 1 694 1 5459,	
excepción 2 694 2 1991,7692,	
1999 1 694 1 5629,	
(a 2 694 2 1990,7691,	
anormalidades 2 694 2 1987,7688,	
media 1 694 1 4068,	
adversos 4 694 4 1985,2017,7686,7718,	
efectos 14 694 14 1984,2016,2304,2632,2654,5273,5294,5309,5426,7685,7717,8005,8332,8354,	
incidencia 9 694 9 1982,2134,2163,2301,4747,7683,7835,7864,8002,	
Reacciones 2 694 2 1966,7667,	
8 5 694 5 1965,3424,4442,5605,7666,	
máquinas 4 694 4 1950,1963,7651,7664,	
conducir 4 694 4 1947,1960,7648,7661,	
Efectos 2 694 2 1942,7643,	
7 10 694 10 1941,3086,3267,4404,4459,4592,5059,5586,7642,8979,	
amamanten 2 694 2 1936,7636,	
madres 2 694 2 1930,7630,	
humana 2 694 2 1914,7614,	
leche 2 694 2 1913,7613,	
excretada 2 694 2 1910,7610,	
Lactancia 2 694 2 1903,7603,	
embarazo 2 694 2 1898,7598,	
primeros 2 694 2 1895,7595,	
tres 2 694 2 1894,7594,	
predictivos 2 694 2 1881,7581,	
reproducción 3 694 3 1875,5413,7575,	
Aunque 2 694 2 1871,7571,	
parto 2 694 2 1870,7570,	
lineal 1 694 1 4933,	
umbilical 2 694 2 1867,7567,	
cordón 2 694 2 1866,7566,	
madre 2 694 2 1863,7563,	
similares 4 694 4 1854,1917,7554,7617,	
nacer 2 694 2 1852,7552,	
niño 2 694 2 1850,7550,	
placenta 2 694 2 1841,7541,	
Comparable 2 694 2 3642,9354,	
pasiva 2 694 2 1833,7533,	
consecuencia 2 694 2 1829,7529,	
Como 4 694 4 1828,4305,5375,7528,	
humanos 6 694 6 1827,1886,2407,7527,7586,8108,	
seres 2 694 2 1826,7526,	
reproductiva 2 694 2 1816,7516,	
toxicidad 8 694 8 1815,2376,2388,5251,5261,7515,8077,8089,	
mostrado 4 694 4 1814,5418,5425,7514,	
lactancia 2 694 2 1795,7495,	
Embarazo 4 694 4 1793,1796,7493,7496,	
18% 1 694 1 4546,	
utilización 4 694 4 1784,1803,7484,7503,	
utilizan 2 694 2 1773,7473,	
zalcitabina 4 694 4 1768,1790,7468,7490,	
intracelular 4 694 4 1766,2540,7466,8240,	
fosforilación 2 694 2 1765,7465,	
debajo 4 694 4 2730,3703,8429,9414,	
inhibir 2 694 2 1763,7463,	
hepatocitos 2 694 2 2545,8245,	
formales 2 694 2 1758,7458,	
A) 2 694 2 1750,7450,	
ciclosporina 2 694 2 1749,7449,	
(p 2 694 2 1747,7447,	
utilizados 3 694 3 1746,5573,7446,	
Límpida 1 694 1 5720,	
comúnmente 2 694 2 1745,7445,	
periférica 2 694 2 2286,7987,	
tomando 2 694 2 1737,7437,	
adversas 14 694 14 1732,1967,2050,2068,2116,2140,2173,7432,7668,7751,7769,7817,7841,7874,	
administran 2 694 2 1724,7424,	
interferón-alfa 2 694 2 1719,7419,	
farmacocinéticas 3 694 3 1717,4783,7417,	
ejerce 2 694 2 1715,7415,	
) 4 694 4 1712,6403,7412,8809,	
apreciables 2 694 2 2656,8356,	
carece 3 694 3 1700,5211,7400,	
Zidovudina 2 694 2 1699,7399,	
observaron 6 694 6 1730,2297,5272,5311,7430,7998,	
alteró 2 694 2 1695,7395,	
general 2 694 2 1691,7391,	
(28 2 694 2 1680,7380,	
(12/95) 1 694 1 4735,	
Cmax 4 694 4 1679,4842,4876,7379,	
incremento 2 694 2 1674,7374,	
modesto 2 694 2 1673,7373,	
observó 5 694 5 1671,3773,4201,7371,9484,	
presente 2 694 2 1659,7359,	
obstante 5 694 5 1653,1752,4884,7353,7452,	
sulfametoxazol 2 694 2 1651,7351,	
ningún 7 694 7 1643,2390,2967,5263,7343,8091,8670,	
negativo 2 694 2 3149,8859,	
ejerció 2 694 2 1642,7342,	
Lamivudina 23 694 23 1640,1713,1761,1968,2490,2515,2552,3583,4785,4929,4998,5061,5319,5350,5434,7340,7413,7461,7669,8190,8215,8252,9295,	
30/69 2 694 2 3789,9500,	
% 19 694 19 1639,2724,2754,2779,2786,2816,2928,3010,4808,5089,7339,8423,8455,8480,8487,8517,8630,8714,8807,	
40 2 694 2 1638,7338,	
alrededor 2 694 2 1635,7335,	
global 2 694 2 4399,4467,	
(NUCAB3017) 2 694 2 3763,9474,	
exposición 6 694 6 1631,1690,5218,5447,7331,7390,	
incrementó 2 694 2 1629,7329,	
mg/800 2 694 2 1627,7327,	
160 2 694 2 1626,7326,	
trimetoprima/sulfametoxazol 2 694 2 1625,7325,	
significativas 4 694 4 1619,1734,7319,7434,	
den 2 694 2 1614,7314,	
glomerular 3 694 3 1613,5073,7313,	
filtración 3 694 3 1612,5072,7312,	
aniónica 2 694 2 1607,7307,	
excretarse 2 694 2 1601,7301,	
hayan 2 694 2 1599,7299,	
sustancias 3 694 3 1597,5018,7297,	
probable 2 694 2 1595,7295,	
interaccionar 2 694 2 1590,7290,	
demostraron 2 694 2 1588,7288,	
parte 3 694 3 1586,5067,7286,	
mecanismo 2 694 2 1583,7283,	
eliminan 2 694 2 1580,7280,	
cimetidina) 2 694 2 1578,7278,	
sistémico 1 694 1 5040,	
ranitidina 2 694 2 1577,7277,	
ej 4 694 4 1576,1748,7276,7448,	
(por 2 694 2 1575,7275,	
ejemplo 2 694 2 1570,7270,	
catiónico 3 694 3 1568,5080,7268,	
hora 1 694 1 4829,	
transporte 3 694 3 1567,5079,7267,	
sistema 7 694 7 1565,2053,2195,4963,7265,7754,7896,	
vía 8 694 8 1555,1606,4799,4813,4917,4990,7255,7306,	
principal 3 694 3 1554,5265,7254,	
especialmente 2 694 2 1551,7251,	
administrados 2 694 2 1547,7247,	
posibilidad 2 694 2 1540,7240,	
(5%) 2 694 2 3830,9543,	
orgánica 4 694 4 1535,1608,7235,7308,	
catiónica 2 694 2 1534,7234,	
secreción 5 694 5 1533,1560,5075,7233,7260,	
predominantemente 2 694 2 1531,7231,	
elimina 3 694 3 1530,5000,7230,	
inalterada 4 694 4 1526,5008,5068,7226,	
sustancia 7 694 7 1525,1836,2635,5007,7225,7536,8335,	
eliminación 9 694 9 1521,1557,5053,5092,5107,5566,5568,7221,7257,	
magnesio 1 694 1 5507,	
generalmente 2 694 2 3342,9055,	
260 4 694 4 3147,3170,8857,8880,	
proteínas 4 694 4 1514,4946,5035,7214,	
unión 4 694 4 1512,4944,5033,7212,	
metabolismo 5 694 5 1510,2589,5026,7210,8289,	
047) 1 694 1 4462,	
hepatomegalia 2 694 2 2329,8030,	
escasa 3 694 3 1507,5032,7207,	
metabólicas 3 694 3 1505,5013,7205,	
probabilidad 3 694 3 1502,5010,7202,	
realizado 7 694 7 1497,1756,1954,4228,7197,7456,7655,	
interacciones 13 694 13 1494,1504,1542,1617,1716,1731,5012,7194,7204,7242,7317,7416,7431,	
estudios 32 694 32 1492,1757,1810,1873,1955,1973,2374,2627,2703,2848,3520,3570,4229,4237,4912,5098,5249,5317,5410,5470,7192,7457,7510,7573,7656,7674,8075,8327,8403,8549,9232,9282,	
interacción 4 694 4 1490,1760,7190,7460,	
Chiron 2 694 2 3263,8975,	
formas 2 694 2 1488,7188,	
Interacción 2 694 2 1481,7181,	
adecuadas 2 694 2 1477,7101,	
tomarse 2 694 2 1474,7098,	
mínimos 1 694 1 4854,	
deberán 2 694 2 1473,7097,	
incorporación 2 694 2 2572,8272,	
personas 2 694 2 1469,7093,	
demostrado 5 694 5 1455,1600,4417,7079,7300,	
informarse 2 694 2 1443,7067,	
frente 10 694 10 1433,2497,4118,4408,4439,4456,4543,4738,7057,8197,	
inmunización 2 694 2 1432,7056,	
establecerá 1 694 1 5579,	
recomendados 2 694 2 1430,7054,	
18/39 2 694 2 3296,9008,	
estándar 4 694 4 1429,2444,7053,8146,	
puente 4 694 4 2860,2893,8561,8594,	
procedimientos 2 694 2 1428,7052,	
seguir 2 694 2 1426,7050,	
mujeres 4 694 4 1416,1807,7040,7507,	
virus 8 694 8 1410,1435,1462,2499,7034,7059,7086,8199,	
fetal 2 694 2 1408,7032,	
materno 2 694 2 1407,7031,	
transmisión 6 694 6 1406,1460,1832,7030,7084,7532,	
dispone 12 694 12 1401,2127,2393,3271,3746,4956,5155,7025,7828,8094,8983,9457,	
Transmisión 2 694 2 1395,7018,	
sólo 8 694 8 1385,1498,1584,3284,7008,7198,7284,8996,	
utilizar 6 694 6 1384,1949,1962,7007,7650,7663,	
mutación 2 694 2 1380,7003,	
antirretroviral 2 694 2 1375,6998,	
antirretrovirales) 2 694 2 1360,6983,	
capacidad 4 694 4 1945,1958,7646,7659,	
mg/dos 2 694 2 1352,6975,	
150 2 694 2 1351,6974,	
infección 4 694 4 1347,2275,6970,7976,	
7% 1 694 1 4412,	
prescrita 2 694 2 1344,6967,	
mantenerse 2 694 2 1339,6962,	
recibir 2 694 2 1329,6952,	
planes 2 694 2 1328,6951,	
recibiendo 2 694 2 1323,6946,	
estén 4 694 4 1322,1419,6945,7043,	
infectados 6 694 6 1313,1364,2513,6936,6987,8213,	
VIH 14 694 14 1307,1319,1349,1370,1382,2277,2348,6930,6942,6972,6993,7005,7978,8049,	
Co-infección 2 694 2 1305,6928,	
signos 6 694 6 1287,2423,3977,6910,8124,9691,	
experimenten 2 694 2 1286,6909,	
posible 2 694 2 1282,6905,	
antígeno/anticuerpo 2 694 2 1270,6893,	
situación 2 694 2 1268,6891,	
sangre 4 694 4 1265,2192,6888,7893,	
ureico 2 694 2 1263,6886,	
nitrógeno 2 694 2 1262,6885,	
encontradas 4 694 4 1857,1920,7557,7620,	
albúmina 2 694 2 1261,6884,	
embarazadas 4 694 4 1417,1808,7041,7508,	
bilirrubina 6 694 6 1260,3549,3622,6883,9261,9334,	
mínimo) 2 694 2 1256,6879,	
(como 2 694 2 1255,6878,	
carcinoma 1 694 1 4451,	
incluir 2 694 2 1254,6877,	
razón 2 694 2 1238,6861,	
mes) 2 694 2 1229,6852,	
(al 2 694 2 1226,6849,	
antiviral 6 694 6 1222,2494,3435,6845,8194,9147,	
funciones 3 694 3 1216,5280,6839,	
asociados 2 694 2 1211,6834,	
permanente 2 694 2 2674,8374,	
serológicos 2 694 2 1210,6833,	
virológicos 2 694 2 1208,6831,	
clínicos 8 694 8 1207,1974,2155,5318,5373,6830,7675,7856,	
parámetros 4 694 4 1206,1248,6829,6871,	
controlar 6 694 6 1204,1252,1298,6827,6875,6921,	
deberían 4 694 4 1203,1253,6826,6876,	
mortal 2 694 2 1198,6821,	
e 6 694 6 1196,3371,3881,6819,9084,9594,	
descompensación 3 694 3 1194,4223,6817,	
tolerada 2 694 2 1971,7672,	
inducir 2 694 2 1192,6815,	
interrumpir 4 694 4 1178,3345,6801,9058,	
reactivación 2 694 2 1173,6796,	
Debido 2 694 2 1161,6784,	
mayor 9 694 9 1155,2854,3466,4288,4478,5066,6778,8555,9178,	
presentan 4 694 4 1153,2047,6776,7748,	
diabéticos 1 694 1 7133,	
avanzada 3 694 3 1152,4360,6775,	
aplicará 2 694 2 2439,8141,	
post 2 694 2 1140,6763,	
presenten 2 694 2 1135,6758,	
reiniciación 2 694 2 1127,6750,	
- 17 694 17 3116,3120,3126,3142,3145,3160,3168,4334,4351,8826,8830,8836,8852,8855,8870,8878,8933,	
beneficios 2 694 2 1124,6747,	
suficientes 4 694 4 1121,1800,6744,7500,	
existen 4 694 4 1119,1798,6742,7498,	
16-18 2 694 2 2778,8479,	
combinación 8 694 8 1336,1357,1788,2340,6959,6980,7488,8041,	
muertes 4 694 4 1117,2248,6740,7949,	
observado 6 694 6 1115,2247,3464,6738,7948,9176,	
autolimitadas 1 694 1 1110,	
reacciones 14 694 14 1107,2049,2067,2115,2124,2139,2172,6730,7750,7768,7816,7825,7840,7873,	
mayoría 8 694 8 1104,2121,2239,3735,6727,7822,7940,9446,	
Clínica 4 694 4 1102,2690,6725,8390,	
Experiencia 11 694 11 1101,2689,2691,3661,4213,4353,4594,6724,8389,8391,9373,	
Sección 2 694 2 1098,6721,	
véase 2 694 2 1092,6715,	
frecuencia 11 694 11 1084,1301,2057,2061,3467,5314,6707,6924,7758,7762,9179,	
referente 2 694 2 1081,6704,	
además 2 694 2 1070,6693,	
sido 4 694 4 1062,1109,6685,6732,	
análogo 2 694 2 2484,8184,	
náuseas 2 694 2 2040,7741,	
La 43 694 43 1056,1103,1501,1527,1622,1981,2238,2371,2538,2563,2887,2949,3016,3531,4098,4161,4463,4548,4629,4695,4746,4860,5009,5050,5137,5243,5567,5647,6679,6726,7154,7201,7227,7322,7682,7939,8072,8238,8263,8588,8652,8720,9243,	
clínicamente 9 694 9 1054,1618,1733,4376,5214,5295,6677,7318,7433,	
según 10 694 10 1052,1302,3079,3095,3275,6675,6925,8783,8798,8987,	
conocer 1 694 1 4688,	
luego 2 694 2 1051,6674,	
hombre 1 694 1 5454,	
cuatro 2 694 2 1048,6671,	
auto­limitadas 1 694 1 6733,	
bilirrubina) 2 694 2 1044,6667,	
(niveles 2 694 2 1040,6663,	
función 10 694 10 1036,1167,2645,4206,4891,5168,5206,6659,6790,8345,	
pruebas 3 694 3 1033,5388,6656,	
evaluación 4 694 4 1030,3281,6653,8993,	
controlarse 2 694 2 1016,6639,	
laboratorio 6 694 6 1005,1250,1989,6628,6873,7690,	
clínico 6 694 6 1002,1024,3442,6625,6647,9154,	
UB6 1 694 1 5600,	
vista 4 694 4 1001,1023,6624,6646,	
punto 4 694 4 999,1021,6622,6644,	
sintomatología 4 694 4 992,1136,6615,6759,	
presentar 4 694 4 991,3742,6614,9453,	
descompensada) 2 694 2 941,6565,	
cirrosis 12 694 12 940,2823,2952,2974,3871,4362,4381,6564,8524,8655,8677,9584,	
(aumento 2 694 2 934,6558,	
empeoramiento 10 694 10 930,2938,3309,3327,3984,6554,8641,9021,9039,9698,	
re-emergencia 4 694 4 916,1073,6540,6696,	
elevaciones 12 694 12 911,1066,1086,3468,3495,3537,6535,6689,6709,9180,9207,9249,	
principalmente 10 694 10 909,1064,1602,2228,4633,5001,6533,6687,7302,7929,	
detectada 4 694 4 908,1063,6532,6686,	
exacerbación 4 694 4 904,1057,6528,6680,	
VHB) 2 694 2 888,6512,	
(variante 2 694 2 885,6509,	
reducida 3 694 3 882,4037,6506,	
sensibilidad 2 694 2 881,6505,	
virales 2 694 2 876,6500,	
subpoblaciones 2 694 2 875,6499,	
identificado 4 694 4 874,2420,6498,8121,	
(en 3 694 3 2814,4890,8515,	
han 33 694 33 873,1108,1114,1496,1755,1813,1953,2221,2240,2246,2279,2317,2350,2419,3463,4227,5417,5424,6497,6731,6737,7196,7455,7513,7654,7922,7941,7947,7980,8018,8051,8120,9175,	
prolongado 6 694 6 871,2980,3755,6495,8683,9466,	
Con 2 694 2 868,6492,	
Exacerbaciones 2 694 2 864,6488,	
determinar 4 694 4 853,3402,6477,9115,	
intervalos 2 694 2 846,6470,	
monitorizarse 2 694 2 839,6463,	
zidovudina 2 694 2 1683,7383,	
Deben 1 694 1 838,	
regular 2 694 2 837,6461,	
Durante 4 694 4 825,2211,6449,7912,	
cáncer 2 694 2 823,6448,	
concurrentes 1 694 1 819,	
inmunodepresores 4 694 4 818,1744,6444,7444,	
reciben 2 694 2 816,6442,	
mutante 2 694 2 810,6436,	
(con 2 694 2 809,6435,	
relación 2 694 2 800,6426,	
limitados 8 694 8 798,1515,2396,4952,5151,6424,7215,8097,	
son 8 694 8 797,1879,2117,3341,6423,7579,7818,9054,	
C 2 694 2 794,6420,	
Delta 2 694 2 791,6417,	
coinfectados 2 694 2 788,6414,	
comparativos 2 694 2 3274,8986,	
establecido 3 694 3 781,3993,6407,	
actualmente 2 694 2 773,6398,	
población 5 694 5 767,4338,4630,4725,6392,	
limitaciones 2 694 2 757,6382,	
embargo 7 694 7 753,1112,3351,4511,6378,6735,9064,	
Sin 5 694 5 752,3350,4510,6377,9063,	
administrado 3 694 3 736,4601,6361,	
julio 1 694 1 5638,	
Se 20 694 20 734,1424,1670,1821,1923,2316,2349,2392,3745,4642,4686,6359,7048,7370,7521,7623,8017,8050,8093,9456,	
precauciones 4 694 4 730,1476,6355,7100,	
Advertencias 2 694 2 728,6353,	
activo 4 694 4 719,2496,6344,8196,	
principio 2 694 2 718,6343,	
Hipersensibilidad 2 694 2 716,6341,	
Contraindicaciones 2 694 2 715,6340,	
esté 9 694 9 708,1053,1303,1325,5183,6333,6676,6926,6948,	
necesario 7 694 7 696,1664,2447,5118,6321,7364,8149,	
Según 3 694 3 691,4910,6316,	
disfunción 4 694 4 689,5115,5186,6314,	
significativa 8 694 8 686,1698,2715,4421,4722,6311,7398,8415,	
mayores) 2 694 2 744,6369,	
afectada 5 694 5 683,4897,5112,5144,6308,	
ve 4 694 4 682,5111,5143,6307,	
farmacocinética 9 694 9 677,1647,1705,4932,5138,5177,6302,7347,7405,	
demuestran 4 694 4 674,5104,5162,6299,	
trasplante 10 694 10 673,947,1145,4250,4275,4340,5160,6298,6571,6768,	
espera 2 694 2 671,6296,	
terminal 2 694 2 668,6293,	
fase 2 694 2 667,6292,	
doble 2 694 2 4014,5554,	
incluyendo 6 694 6 661,820,2267,6286,6445,7968,	
animales 10 694 10 1812,1877,2379,2512,5253,5415,7512,7577,8080,8212,	
obtenidos 2 694 2 655,6280,	
diálisis 2 694 2 650,6275,	
1/100) 2 694 2 2095,7796,	
ajustes 2 694 2 642,6267,	
precisan 2 694 2 641,6266,	
paciente 12 694 12 638,1658,2436,2968,3633,3863,6263,7358,8138,8671,9345,9576,	
ajustar 6 694 6 632,697,1665,6257,6322,7365,	
asoció 1 694 1 5259,	
inicial 2 694 2 628,6253,	
séricas 1 694 1 4822,	
semana) 2 694 2 619,6244,	
veces 7 694 7 616,1353,2321,5366,6241,6976,8022,	
%) 3 694 3 1681,4882,7381,	
2-3 2 694 2 615,6240,	
h 2 694 2 614,6239,	
igual 2 694 2 611,6236,	
(diálisis 2 694 2 608,6233,	
intermitente 2 694 2 607,6232,	
reducción 8 694 8 624,1164,3936,4420,5300,6249,6787,9649,	
hemodiálisis 4 694 4 606,2456,6231,8158,	
sometidos 4 694 4 604,5158,5406,6229,	
disponibles 2 694 2 601,6226,	
Los 28 694 28 599,795,1142,1247,1283,1491,1809,2015,3188,3216,4950,5097,5149,5293,5409,5466,6224,6421,6765,6870,6906,7103,7131,7191,7509,7716,8898,8927,	
mg/ml 3 694 3 596,5677,5690,	
especiales 5 694 5 731,5096,5523,5564,6356,	
conteniendo 2 694 2 594,5541,	
acompañada 3 694 3 709,5184,6334,	
*Zeffix 1 694 1 591,	
<15 2 694 2 589,6222,	
<30 2 694 2 586,6219,	
15 2 694 2 584,6217,	
<50 2 694 2 583,6208,	
30 2 694 2 581,6206,	
sea 4 694 4 1558,2446,7258,8148,	
* 3 694 3 576,3631,9343,	
(3/56) 2 694 2 2920,8622,	
ml/min 4 694 4 573,5132,5232,6199,	
mantenimiento 2 694 2 572,6198,	
retirada 2 694 2 2217,7918,	
Dosis 2 694 2 570,6196,	
Primera 2 694 2 566,6192,	
(normalmente 2 694 2 1350,6973,	
Aclaramiento 2 694 2 563,6189,	
disminuido 2 694 2 562,6188,	
Dosificación 2 694 2 554,6180,	
continuación) 4 694 4 551,2001,6177,7702,	
Tabla 14 694 14 548,552,1094,3070,3087,3487,3562,6174,6178,6717,8774,8790,9199,9274,	
(ver 4 694 4 547,2207,6173,7908,	
conjuntivo 2 694 2 2258,7959,	
oral 14 694 14 546,575,593,1907,4800,4814,4991,5679,5687,5719,6201,7143,7156,7607,	
solución 12 694 12 545,574,592,2740,3253,5678,5686,6200,7142,7155,8441,8965,	
3) 2 694 2 1820,7520,	
utilizarse 1 694 1 543,	
inferiores 1 694 1 538,	
precisen 3 694 3 536,1373,6996,	
Cuando 4 694 4 534,3727,4268,9438,	
ml/minuto 2 694 2 533,6172,	
50 4 694 4 532,5131,5231,6171,	
inferior 5 694 5 530,4877,5129,5229,6169,	
máximo 1 694 1 4654,	
creatinina 10 694 10 529,565,636,1266,5128,5228,6168,6191,6261,6889,	
reducirse 2 694 2 520,6159,	
Por 6 694 6 516,1777,3388,6155,7477,9101,	
diferencia 1 694 1 4696,	
aclaramiento 12 694 12 514,527,560,634,5039,5083,5126,5226,6153,6166,6186,6259,	
disminución 4 694 4 512,4067,5203,6151,	
primera 1 694 1 5625,	
grave 6 694 6 508,1195,2330,6147,6818,8031,	
moderada 2 694 2 506,6145,	
insuficiencia 16 694 16 504,659,703,711,1289,1660,5102,5147,5165,6143,6284,6328,6336,6912,7123,7360,	
aumentan 2 694 2 500,6139,	
(AUC) 4 694 4 499,1692,6138,7392,	
suero 16 694 16 498,1039,1259,1275,1848,1860,1922,2237,6137,6662,6882,6898,7548,7560,7622,7938,	
concentraciones 12 694 12 494,1273,1843,1916,2233,4821,5362,6133,6896,7543,7616,7934,	
renal 25 694 25 492,505,515,561,712,1217,1522,1561,1661,5004,5084,5103,5116,5187,5207,5283,6131,6144,6154,6187,6337,6840,7222,7261,7361,	
Insuficiencia 4 694 4 491,651,6130,6276,	
seguridad 3 694 3 484,5242,6123,	
ausencia 3 694 3 480,5485,6119,	
debido 12 694 12 477,509,754,975,1508,4309,5021,6116,6148,6379,6598,7208,	
años 28 694 28 469,476,742,2831,3006,3049,3094,3215,3241,3287,3766,3921,4628,4668,4683,5519,6108,6115,6367,8532,8710,8753,8797,8926,8953,8999,9477,9634,	
indican 4 694 4 620,3671,6245,9383,	
menores 5 694 5 466,3061,5274,6105,8765,	
quimioterapia 2 694 2 821,6446,	
niños 12 694 12 465,739,1441,1939,4596,4604,4635,4660,6104,6364,7065,7639,	
recomendado 2 694 2 461,6100,	
17 7 694 7 456,475,4411,4627,6095,6114,7640,	
(de 4 694 4 453,740,6092,6365,	
adolescentes 9 694 9 452,471,746,4598,4606,4680,6091,6110,6371,	
años) 4 694 4 450,457,6089,6096,	
12 11 694 11 449,454,468,473,4682,4996,5604,6088,6093,6107,6112,	
(menores 2 694 2 447,6086,	
Niños 2 694 2 446,6085,	
(blister) 1 694 1 5552,	
4) 9 694 9 445,1902,2210,2252,4010,6084,7602,7911,7953,	
recurrente 9 694 9 441,945,995,1139,4151,6080,6569,6618,6762,	
existencia 2 694 2 437,6076,	
administrando 1 694 1 4271,	
comprobar 2 694 2 435,6074,	
periódicamente 6 694 6 433,1017,3400,6072,6640,9113,	
controlados 14 694 14 432,834,2704,2849,3399,3571,4230,4239,6071,6458,8404,8550,9112,9283,	
interrumpe 8 694 8 423,963,1008,1233,6062,6586,6631,6856,	
alternativos 2 694 2 416,6055,	
adicionales 4 694 4 414,645,6053,6270,	
tratamientos 4 694 4 413,817,6052,6443,	
deben 17 694 17 411,430,832,852,1015,1297,1425,3397,6050,6069,6456,6638,6920,7049,7127,7134,9110,	
aparición 8 694 8 401,3874,3896,4317,5401,6040,9587,9609,	
atribuible 2 694 2 398,6037,	
eficacia 14 694 14 397,486,783,974,1187,3091,3674,6036,6125,6409,6597,6810,8794,9386,	
pérdida 9 694 9 395,972,1185,2770,4289,6034,6595,6808,8471,	
produce 4 694 4 393,970,6032,6593,	
Si 8 694 8 391,421,961,1006,6030,6060,6584,6629,	
hepático 7 694 7 390,948,4155,5027,5161,6029,6572,	
transplante 3 694 3 389,4154,6028,	
confirmarse 1 694 1 5385,	
receptores 4 694 4 387,1143,6026,6766,	
enfermedad 19 694 19 382,664,932,1150,2699,3981,4027,4145,4217,4402,4470,4516,4534,6021,6289,6556,6773,8399,9695,	
indica 1 694 1 5196,	
lamivudina/zidovudina 2 694 2 1337,6960,	
recomienda 8 694 8 374,1782,1889,1924,6013,7482,7589,7624,	
No 26 694 26 372,778,1118,1399,1593,1652,1728,1751,1951,2408,2417,4883,5511,5526,6011,6404,6741,7023,7293,7352,7428,7451,7652,8109,8118,8811,	
alternativo 6 694 6 366,960,3436,6004,6583,9148,	
agente 8 694 8 365,959,2493,3434,6003,6582,8193,9146,	
adición 6 694 6 362,956,4042,4162,6000,6579,	
Cada 2 694 2 3632,9344,	
cambio 4 694 4 358,952,5997,6576,	
prolongada 2 694 2 348,5987,	
anteriores 2 694 2 340,5979,	
respecto 10 694 10 336,2944,3833,3857,3967,5975,8647,9546,9570,9681,	
ALT 58 694 58 334,843,913,936,1042,1068,1088,1257,1996,2206,2235,2752,2997,3038,3121,3127,3159,3470,3497,3539,3566,3585,3594,3603,3609,3616,3780,3966,4104,4267,5973,6467,6537,6560,6665,6691,6711,6880,7697,7907,7936,8453,8700,8742,8831,8837,8869,9182,9209,9251,9278,9297,9306,9315,9321,9328,9491,9679,	
frecuencias 6 694 6 2077,2110,2136,7778,7811,7837,	
aumento 10 694 10 326,2230,3544,3951,4082,4430,5966,7931,9256,9664,	
(los 1 694 1 4726,	
indicada 2 694 2 323,5963,	
terapéutica 2 694 2 320,5960,	
38/214 1 694 1 4545,	
respuesta 15 694 15 319,1221,1884,3335,3417,3885,3939,4033,5959,6844,7584,9048,9130,9598,9652,	
menor 6 694 6 318,609,4284,4528,5958,6234,	
dar 4 694 4 314,901,5954,6525,	
existe 2 694 2 1376,6999,	
YMDD 56 694 56 310,352,405,886,897,926,981,2865,2883,2905,2924,2936,2964,3085,3099,3107,3193,3199,3278,3293,3816,3878,3900,3929,4004,4023,4160,4321,4489,4520,4751,5950,5991,6044,6510,6521,6550,6604,8566,8584,8606,8626,8638,8667,8789,8802,8817,8903,8910,8934,8990,9005,9529,9591,9613,9642,	
variante 59 694 59 309,351,404,896,925,980,2864,2882,2904,2914,2923,2935,2963,2971,3084,3106,3192,3198,3221,3292,3315,3815,3842,3877,3899,3928,4003,4022,4159,4320,4488,4507,4750,5949,5990,6043,6520,6549,6603,8565,8583,8605,8616,8625,8637,8666,8674,8788,8816,8902,8909,8932,9004,9027,9528,9555,9590,9612,9641,	
desarrollo 9 694 9 306,893,977,3925,4449,5946,6517,6600,9638,	
EU/1/99/114/001 1 694 1 5611,	
interrupción 6 694 6 286,376,3454,5926,6015,9166,	
considerarse 13 694 13 284,356,412,950,1538,3421,4234,5924,5995,6051,6574,7238,9134,	
practique 2 694 2 648,6273,	
Debe 7 694 7 283,1442,1537,5923,6462,7066,7237,	
óptima 2 694 2 280,5920,	
duración 5 694 5 279,347,4391,5919,5986,	
desconoce 4 694 4 277,1822,5917,7522,	
pre-core) 4 694 4 275,811,5915,6437,	
(mutante 2 694 2 274,5914,	
esteatosis 2 694 2 2332,8033,	
través 4 694 4 1027,1838,6650,7538,	
negativos 14 694 14 273,304,808,3667,3682,3759,4139,4580,5913,5944,6434,9379,9394,9470,	
HBC 16 694 16 271,298,2695,3665,3680,3690,4019,4349,4357,4608,5911,5938,8395,9377,9392,9402,	
1) 6 694 6 266,370,420,777,6008,6059,	
5 43 694 43 265,369,419,489,587,595,776,1099,1480,1710,1819,2470,2478,3005,3048,3093,3138,3214,3240,4780,4849,5057,5237,5534,5676,5689,5905,6007,6058,6128,6220,6401,6722,7180,7410,7519,8172,8709,8752,8796,8848,8925,8952,	
	Solución 1 694 1 5718,	
(véase 25 694 25 263,367,417,442,487,774,984,1708,1817,1899,2249,4007,5133,5233,5903,6005,6056,6081,6126,6399,6607,7408,7517,7599,7950,	
(14/45) 1 694 1 4110,	
datos 33 694 33 262,482,600,654,693,760,796,1120,1799,2129,2152,2395,3273,3669,3748,4690,4951,5150,5902,6121,6225,6279,6318,6385,6422,6743,7499,7830,7853,8096,8985,9381,9459,	
limitado 2 694 2 260,5900,	
número 2 694 2 259,5899,	
Valor 2 694 2 3581,9293,	
basada 2 694 2 256,5896,	
recomendación 2 694 2 254,5894,	
Esta 3 694 3 253,5893,7174,	
lugar 17 694 17 248,315,902,1615,2851,3893,4064,4184,4286,4867,5360,5888,5955,6526,7315,8552,9606,	
tenga 2 694 2 247,5887,	
2) 6 694 6 490,987,5136,5236,6129,6610,	
virológica 7 694 7 243,1269,3379,4034,5883,6892,9092,	
recaída 4 694 4 242,3378,5882,9091,	
riesgo 11 694 11 240,1156,1378,1458,1824,5399,5880,6779,7001,7082,7524,	
reducir 5 694 5 238,1456,5119,5878,7080,	
HBeAc) 3 694 3 233,4714,5873,	
detección 9 694 9 231,2735,2766,3707,4712,5871,8434,8467,9418,	
VHB 75 694 75 229,312,331,354,407,857,878,899,920,928,983,1077,1271,1279,2562,2721,2774,2867,2885,3058,3135,3201,3295,3444,3700,3787,3818,3880,3902,3931,3958,4006,4025,4072,4150,4193,4259,4282,4323,4493,4579,4710,4753,5869,5952,5971,5993,6046,6481,6502,6523,6544,6552,6606,6700,6894,6902,8262,8421,8475,8568,8586,8762,8819,8845,8912,9007,9156,9411,9498,9531,9593,9615,9644,9671,	
ADN 46 694 46 227,329,855,918,1075,1277,2567,2605,2619,2647,2667,2676,2685,2719,2772,3056,3133,3698,3785,3956,4070,4191,4257,4491,4577,4708,5867,5969,6479,6542,6698,6900,8267,8305,8319,8347,8367,8376,8385,8419,8473,8760,8843,9409,9496,9669,	
(pérdida 5 694 5 223,2762,4704,5863,8463,	
seroconversión 24 694 24 220,250,291,2759,2839,2988,3017,3331,3357,3370,3392,4549,4701,5860,5890,5931,8460,8540,8691,8721,9044,9070,9083,9105,	
confirme 2 694 2 218,5858,	
después 12 694 12 214,1244,1293,2425,3459,4273,4728,5854,6867,6916,8126,9171,	
meses 14 694 14 213,849,863,1049,1243,1896,4389,4779,5853,6473,6487,6672,6866,7596,	
3-6 2 694 2 212,5852,	
durante 33 694 33 209,341,1045,1188,1223,1239,1291,1892,2177,2707,2829,3208,3236,3972,4060,4180,4248,4581,4777,5849,5980,6668,6811,6846,6862,6914,7592,7878,8407,8530,8919,8948,9686,	
positivos 8 694 8 204,301,2697,3692,5842,5941,8397,9404,	
HBeAg 45 694 45 203,222,225,272,300,303,807,860,2696,2761,2764,2841,2990,3019,3111,3333,3394,3666,3681,3691,3758,4141,4551,4703,4706,5841,5862,5865,5912,5940,5943,6433,6484,8396,8462,8465,8542,8693,8723,9046,9107,9378,9393,9403,9469,	
(HBC) 2 694 2 202,5840,	
pacientes 185 694 185 197,269,296,345,380,410,429,502,524,558,603,657,701,769,787,806,831,891,922,989,1014,1133,1148,1171,1201,1284,1312,1363,1446,1736,1976,2006,2273,2290,2307,2346,2358,2414,2693,2727,2788,2834,2862,2880,2901,2911,2919,2932,2960,2982,3022,3034,3052,3119,3189,3217,3289,3312,3367,3396,3412,3446,3473,3480,3506,3516,3534,3555,3663,3678,3688,3697,3738,3757,3796,3810,3812,3839,3909,3944,4000,4017,4091,4113,4137,4215,4221,4346,4355,4371,4426,4481,4518,4560,4570,4618,4772,5100,5123,5157,5189,5223,5405,5835,5909,5936,5984,6019,6049,6068,6141,6163,6184,6228,6282,6326,6394,6413,6432,6455,6515,6546,6612,6637,6756,6771,6794,6824,6907,6935,6986,7070,7104,7132,7436,7677,7707,7974,7991,8008,8047,8059,8115,8393,8426,8489,8535,8563,8581,8602,8613,8621,8634,8663,8685,8726,8738,8756,8829,8899,8928,9001,9024,9080,9109,9125,9158,9185,9192,9218,9228,9246,9267,9375,9390,9400,9408,9449,9468,9507,9523,9525,9552,9622,9657,	
En 49 694 49 196,268,295,344,889,921,1199,1361,2272,2289,2429,2625,2861,2975,3068,3288,3310,3358,3411,3445,3485,3811,3838,4011,4236,5188,5834,5908,5935,5983,6513,6545,6822,6984,7973,7990,8131,8325,8562,8678,8772,9000,9022,9071,9124,9157,9197,9524,9551,	
Duración 2 694 2 192,5830,	
alimentos 4 694 4 191,4865,4908,5829,	
administrarse 6 694 6 187,206,1685,5825,5844,7385,	
día 11 694 11 184,580,1355,4052,4172,4651,4678,4840,5822,6205,6978,	
vez 9 694 9 182,578,4050,4170,4649,4676,4838,5820,6203,	
recomendada 4 694 4 174,772,5812,6397,	
dosis 29 694 29 173,522,537,567,627,644,699,1341,1667,2381,4645,4671,4694,4831,4940,5121,5255,5268,5357,5811,6161,6193,6252,6269,6324,6964,7140,7367,8082,	
Adultos 2 694 2 171,5809,	
experiencia 2 694 2 162,5800,	
ensayo; 2 694 2 3709,9420,	
médico 2 694 2 160,5798,	
iniciado 2 694 2 157,5795,	
debe 14 694 14 155,205,355,519,542,949,1338,5793,5843,5994,6158,6476,6573,6961,	
El 11 694 11 151,2824,2915,3924,4973,5038,5082,5789,8525,8617,9637,	
x 16 694 16 3124,3131,3587,3596,3605,3618,3624,3628,8834,8841,9299,9308,9317,9330,9336,9340,	
efecto 7 694 7 1644,1702,2614,5213,7344,7402,8314,	
administración 16 694 16 150,762,1623,1891,1906,2372,4811,4861,4988,5244,5788,6387,7323,7591,7606,8073,	
Posología 2 694 2 146,5784,	
descompensada 6 694 6 143,384,4147,4219,5781,6023,	
fibrosis 10 694 10 139,2813,2858,2891,4359,4379,5777,8514,8559,8592,	
HBsAg 5 694 5 252,293,4291,5892,5933,	
o 61 694 61 138,189,244,360,415,610,720,792,938,942,954,968,1183,1292,1324,1333,1610,1650,2186,2422,2793,3060,3426,3430,3639,4140,4148,4361,4380,4446,4906,5432,5574,5722,5776,5827,5884,5998,6054,6235,6345,6418,6562,6566,6577,6591,6806,6915,6947,6956,7120,7122,7310,7350,7887,8123,8494,8764,9138,9142,9351,	
mayores 1 694 1 4685,	
activa 13 694 13 135,1160,1536,1562,1609,2534,5076,5773,6783,7236,7262,7309,8234,	
inflamación 6 694 6 133,2873,2941,5771,8574,8644,	
medicamentos 13 694 13 1485,1546,1574,1722,1743,1771,7185,7246,7274,7422,7443,7471,9703,	
histológica 4 694 4 131,3282,5769,8994,	
persistente 2 694 2 128,5766,	
elevados 4 694 4 125,3025,5763,8729,	
sérica 9 694 9 124,844,914,1069,4979,5762,6468,6538,6692,	
(ALT) 2 694 2 123,5761,	
aminotransferasa 2 694 2 122,5760,	
alanina 2 694 2 121,5759,	
(19%) 2 694 2 3593,9305,	
niveles 34 694 34 119,339,841,2947,3024,3036,3054,3064,3547,3778,3836,3860,3954,3964,3970,4102,4853,5371,5445,5757,5978,6465,8650,8728,8740,8758,8768,9259,9489,9549,9573,9667,9677,9684,	
viral 10 694 10 118,1159,2560,2568,3744,5756,6782,8260,8268,9455,	
replicación 8 694 8 117,1158,2717,3743,5755,6781,8417,9454,	
fertilidad 1 694 1 5429,	
evidencia 7 694 7 115,130,3948,5419,5753,5768,9661,	
laminados 1 694 1 5556,	
compensada 9 694 9 113,751,2701,4029,4377,4609,5751,6376,8401,	
hepática 48 694 48 112,134,142,383,652,660,665,690,704,933,1037,1151,1168,1219,1290,2333,2700,2874,2942,3982,4028,4146,4207,4218,4224,5148,5169,5281,5750,5772,5780,6022,6277,6285,6290,6315,6329,6557,6660,6774,6791,6842,6913,8034,8400,8575,8645,9696,	
Enfermedad 4 694 4 111,141,5749,5779,	
· 12 694 12 110,140,195,267,294,371,5748,5778,5833,5907,5934,6010,	
adultos 8 694 8 108,1500,3575,4760,4802,5746,7200,9287,	
crónica 15 694 15 106,170,201,750,1394,1980,2294,4375,5744,5808,5839,6375,7017,7681,7995,	
<5 2 694 2 590,6223,	
B 32 694 32 105,169,200,749,944,1215,1393,1398,1414,1439,1466,1979,2293,2367,2503,4374,4638,5743,5807,5838,6374,6568,6838,7016,7022,7038,7063,7090,7680,7994,8068,8203,	
hepatitis 52 694 52 104,168,199,440,748,790,793,867,907,943,994,1060,1138,1176,1214,1392,1397,1413,1438,1465,1978,2226,2292,2366,2502,4373,4637,5742,5806,5837,6079,6373,6416,6419,6491,6531,6567,6617,6683,6761,6799,6837,7015,7021,7037,7062,7089,7679,7927,7993,8067,8202,	
(23/209 2 694 2 4494,4541,	
tratamiento 110 694 110 101,152,165,194,208,282,288,343,378,425,827,870,965,1010,1091,1129,1141,1180,1190,1225,1235,1246,1295,1310,1330,1374,1389,1421,1450,1932,2213,2364,2441,2460,2706,2825,2979,3003,3041,3067,3347,3374,3425,3456,3510,3530,3726,3731,3754,3768,3887,3941,4054,4174,4212,4330,4385,5408,5739,5790,5803,5832,5846,5922,5928,5982,6017,6064,6451,6494,6588,6633,6714,6752,6764,6803,6813,6848,6858,6869,6918,6933,6953,6997,7012,7045,7074,7632,7914,8065,8143,8162,8406,8526,8682,8706,8745,8771,9060,9087,9137,9168,9222,9242,9437,9442,9465,9479,9600,9654,	
indicado 6 694 6 98,1055,1304,5736,6678,6927,	
está 12 694 12 97,255,460,771,3932,4803,5653,5735,5895,6099,6396,9645,	
trimetoprima 4 694 4 1571,1649,7271,7349,	
terapéuticas 4 694 4 95,4832,4941,5733,	
Indicaciones 2 694 2 94,5732,	
/ 2 694 2 137,5775,	
	4 2 694 2 92,5730,	
CLÍNICOS 2 694 2 91,5729,	
DATOS 3 694 3 90,5490,5728,	
4 46 694 46 89,144,444,613,713,726,727,986,1478,1479,1791,1901,1940,1964,2209,2251,2368,3148,3261,3920,4009,4074,4195,5135,5235,5521,5727,5782,6083,6238,6338,6351,6352,6609,7150,7179,7491,7601,7641,7665,7910,7952,8069,8858,8973,9633,	
" 1 694 1 88,	
cara 1 694 1 87,	
CG5"" 1 694 1 84,	
""GX 1 694 1 83,	
marcados 1 694 1 82,	
biconvexos 1 694 1 80,	
cápsulas 1 694 1 79,	
forma 18 694 18 77,127,148,685,836,1697,2533,2673,2714,4775,5765,5786,6310,6460,7397,8233,8373,8414,	
película 1 694 1 75,	
recubiertos 1 694 1 73,	
caramelo 1 694 1 72,	
color 2 694 2 71,5724,	
Comprimidos 1 694 1 69,	
11 2 694 2 4667,5393,	
	"Comprimidos 1 694 1 65,	
FARMACÉUTICA 2 694 2 64,5717,	
FORMA 2 694 2 63,5716,	
3 31 694 31 62,714,824,848,1095,3144,3248,3286,3488,3563,3595,3647,4086,4437,4454,4927,5048,5238,5514,5518,5715,6339,6472,6718,8854,8960,8998,9200,9275,9307,9359,	
6 22 694 22 60,862,1242,1792,2477,3140,3259,4075,4196,5489,5508,5513,5520,5533,5561,5562,5713,6486,6865,7492,8850,8971,	
sección 27 694 27 59,264,368,418,443,488,775,985,1709,1818,1900,2250,4008,5134,5234,5712,5904,6006,6057,6082,6127,6400,6608,7409,7518,7600,7951,	
mostraron 7 694 7 2937,3821,3845,5483,8639,9534,9558,	
ver 4 694 4 58,1999,5711,7700,	
excipientes 4 694 4 57,725,5496,6350,	
completa 4 694 4 55,1520,5710,7220,	
lista 2 694 2 54,5709,	
Para 6 694 6 52,1078,1308,5707,6701,6931,	
lamivudina 131 694 131 51,322,496,598,630,679,737,764,785,804,884,1131,1182,1332,1343,1386,1423,1452,1528,1592,1621,1633,1669,1687,1707,1738,1805,1845,1908,1934,2014,2075,2219,2315,2361,2385,2450,2651,2711,2828,3349,3376,3429,3477,3559,3676,3733,3762,3891,4039,4059,4095,4125,4179,4245,4272,4387,4407,4476,4526,4563,4573,4602,4718,4797,4863,4888,4901,4915,4959,4981,5015,5043,5094,5109,5140,5179,5195,5220,5246,5382,5395,5477,5692,5962,6135,6255,6304,6362,6389,6411,6430,6508,6754,6805,6955,6966,7009,7047,7076,7228,7292,7321,7333,7369,7387,7407,7438,7505,7545,7608,7634,7715,7776,7920,8016,8062,8086,8152,8351,8411,8529,9062,9089,9141,9189,9271,9388,9444,9473,9604,	
contienen 1 694 1 47,	
cuenta 2 694 2 2161,7862,	
Zeffix 26 694 26 46,96,154,176,185,427,458,544,556,569,829,967,1012,1786,5734,5792,5814,5823,6066,6097,6182,6195,6453,6590,6635,7486,	
	Los 1 694 1 40,	
CUANTITATIVA 2 694 2 39,5684,	
Y 2 694 2 38,5683,	
CUALITATIVA 2 694 2 37,5682,	
COMPOSICIÓN 2 694 2 36,5681,	
temprana 1 694 1 5437,	
2 34 694 34 35,145,741,1711,2796,2830,3071,3088,3130,3244,3569,3586,3604,3617,3627,4624,4665,4781,5509,5680,5783,6366,7411,8497,8531,8775,8791,8840,8956,9281,9298,9316,9329,9339,	
pelicular 4 694 4 34,44,68,5548,	
cubierta 4 694 4 33,43,67,5547,	
comprimidos 3 694 3 31,41,5545,	
mg 15 694 15 30,49,180,541,1628,4045,4057,4165,4177,4657,4674,4836,5818,7145,7328,	
100 10 694 10 29,48,179,540,4056,4176,4656,4673,4835,5817,	
	Zeffix 3 694 3 28,5675,5685,	
MEDICAMENTO 4 694 4 27,2475,5674,8177,	
NOMBRE 2 694 2 25,5672,	
1 31 694 31 23,24,61,93,549,553,1100,2479,2708,2746,3123,3204,3258,4300,4847,4926,5493,5671,5714,5731,5906,6175,6179,6402,6723,8179,8408,8447,8833,8914,8970,	
PRODUCTO 1 694 1 22,	
DEL 4 694 4 21,26,5645,5673,	
grupo 3 694 3 4473,4523,4537,	
CARACTERÍSTICAS 1 694 1 20,	
LAS 1 694 1 19,	
DE 10 694 10 18,2473,5588,5591,5607,5609,5615,5619,5642,8175,	
RESUMEN 1 694 1 17,	
O 1 694 1 16,	
absorción 1 694 1 7116,	
TÉCNICA 1 694 1 15,	
FICHA 1 694 1 14,	
tuvo 2 694 2 2159,7860,	
información 6 694 6 11,1080,1403,5648,6703,7027,	
Toda 1 694 1 9,	
medicamento 4 694 4 8,13,5652,7130,	
Basica 1 694 1 6,	
	Información 1 694 1 5,	
ORAL 1 694 1 4,	
SOLUCION 1 694 1 3,	
240ML 1 694 1 2,	
hallazgos 1 694 1 3986,	
5MG/ML 1 694 1 1,	
Trombocitopenia 2 694 2 2199,7900,	
ZEFFIX 1 694 1 0,	
